Uneven Distribution of Histologic Changes of "Blue Liver" Induced After Oxaliplatin-Based Chemotherapy for Colon Cancer

Int J Surg Pathol. 2020 Aug;28(5):523-525. doi: 10.1177/1066896919883407. Epub 2019 Oct 17.

Authors

Akiko Fujii¹, Teppei Tateoka², Takashi Okuyama², Jun Matsushima¹, Taiki Sato¹, Yuko Ono¹, Shinichi Ban¹

Affiliations

¹ Department of Pathology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
² Departnent of Surgery, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.

PMID: 31623475
DOI: 10.1177/1066896919883407

No abstract available

Publication types

Case Reports

MeSH terms

Antigens, Tumor-Associated, Carbohydrate / blood
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Capecitabine / adverse effects*
Capillaries / pathology
Chemotherapy, Adjuvant / adverse effects
Colectomy
Diagnosis, Differential
Female
Hepatectomy
Hepatic Veno-Occlusive Disease / blood
Hepatic Veno-Occlusive Disease / chemically induced
Hepatic Veno-Occlusive Disease / diagnosis*
Hepatic Veno-Occlusive Disease / pathology
Humans
Liver / blood supply
Liver / drug effects
Liver / pathology*
Liver / surgery
Liver Neoplasms / blood
Liver Neoplasms / diagnosis*
Liver Neoplasms / secondary
Middle Aged
Oxaloacetates / adverse effects*
Sigmoid Neoplasms / pathology
Sigmoid Neoplasms / therapy*
Tomography, X-Ray Computed

Substances

Antigens, Tumor-Associated, Carbohydrate
Oxaloacetates
carbohydrate antigen 199, human
Capecitabine

Supplementary concepts

XELOX